1352874-26-0

Basic information

• Product Name: 1-(4-bromo-phenyl)-3-(2-chloro-benzyl)-1,3-dihydro-benzoimidazol-2-ylideneamine
• Synonyms: 1-(4-bromo-phenyl)-3-(2-chloro-benzyl)-1,3-dihydro-benzoimidazol-2-ylideneamine
• CAS NO: 1352874-26-0
• Molecular Weight: 412.716
• Mol File: 1352874-26-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1-(4-bromo-phenyl)-3-(2-chloro-benzyl)-1,3-dihydro-benzoimidazol-2-ylideneamine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-bromo-phenyl)-3-(2-chloro-benzyl)-1,3-dihydro-benzoimidazol-2-ylideneamine(1352874-26-0)
• EPA Substance Registry System: 1-(4-bromo-phenyl)-3-(2-chloro-benzyl)-1,3-dihydro-benzoimidazol-2-ylideneamine(1352874-26-0)

Safety Data

• Hazardous Substances Data: 1352874-26-0(Hazardous Substances Data)

Upstream product

• 100953-52-4 N¹-(4-bromophenyl)benzene -1,2 -diamine 
• 58476-59-8 4-bromo-N-(2-nitrophenyl)benzenamine 
• 1038374-09-2 1-(4-bromophenyl)-1H-benzo[d]imidazol-2-amine 
• 611-17-6 1-bromomethyl-2-chlorobenzene 
• 1493-27-2 ortho-nitrofluorobenzene 
• 106-40-1 4-bromo-aniline 

Downstream Products

• 1352874-28-2 [1-(4-bromo-phenyl)-3-(2-chloro-benzyl)-1,3-dihydro-benzoimidazol-(2E)-ylidene]-carbamic acid tert-butyl ester 
• 1352873-05-2 N-{5-acetyl-4'-[3-(2-chloro-benzyl)-2-imino-2,3-dihydro-benzoimidazol-1-yl]-biphenyl-2-yl}-acetamide 
• 1352872-60-6 4'-[3-(2-chloro-benzyl)-2-imino-2,3-dihydro-benzoimidazol-1-yl]-biphen-2-ylamine 
• 1352872-32-2 N-{4'-[3-(2-chloro-benzyl)-2-imino-2,3-dihydro-benzoimidazol-1-yl]-biphenyl-4-yl}-acetamide 
• 1352874-51-1 4'-[3-(2-chloro-benzyl)-2-imino-2,3-dihydro-benzoimidazol-1-yl]-4-methyl-biphenyl-2-ylamine trifluoroacetic acid 
• 1352872-96-8 4'-[3-(2-chloro-benzyl)-2-imino-2,3-dihydro-benzoimidazol-1-yl]-5-fluoro-biphenyl-2-ylamine 
• 1352872-31-1 N-{5-chloro-4'-[3-(2-chloro-benzyl)-2-imino-2,3-dihydro-benzoimidazol-1-yl]-biphenyl-2-yl}-acetamide 
• 1352872-61-7 N-{4'-[3-(2-chloro-benzyl)-2-imino-2,3-dihydro-benzoimidazol-1-yl]-biphenyl-2-yl}-3-cyano-benzamide 
• 1352872-84-4 N-{4'-[3-(2-chloro-benzyl)-2-imino-2,3-dihydro-benzoimidazol-1-yl]-4-methyl-biphenyl-2-yl}-acetamide trifluoroacetic acid 
• 1352872-85-5 2-Amino-N-{4'-[3-(2-chloro-benzyl)-2-imino-2,3-dihydro-benzoimidazol-1-yl]-biphenyl-2-yl}-acetamide 
• 1352873-00-7 1-{4'-[3-(2-chloro-benzyl)-2-imino-2,3-dihydro-benzoimidazol-1-yl]-biphenyl-2-yl}-3-methyl-urea trifluoroacetic acid 
• 1352873-11-0 N-[4'-[3-(2-chloro-benzyl)-2-imino-2,3-dihydro-benzoimidazol-1-yl]-5-(1-hydroxy-1-methyl-ethyl)-biphenyl-2-yl]-acetamide trifluoroacetic acid 
• 1352873-13-2 N-(5-chloro-3-{4-[3-(2-chloro-benzyl)-2-imino-2,3-dihydro-benzoimidazol-1-yl]-phenyl}-pyridin-2-yl)-acetamide 
• 1352874-29-3 [1-(2'-amino-biphenyl-4-yl)-3-(2-chloro-benzyl)-1,3-dihydro-benzoimidazol-(2E)-ylidene]-carbamic acid tert-butyl ester 

Relevant articles and documents

BIPHENYL SUBSTITUTED 1,3-DIHYDRO-BENZOIMIDAZOL-2-YLIDENEAMINE DERIVATIVES

The invention relates to new derivatives of formula (I), wherein the substituents are as defined in the specification; to processes for the preparation of such derivatives; pharmaceutical compositions comprising such derivatives; such derivatives as a medicament; such derivatives for the treatment of one or more IGF-1R mediated disorders or diseases